PES News & Announcements
See the latest news and updates from PES.
June 2026 President’s Letter
Dear Colleagues, Welcome to my PES monthly President’s Newsletters! I want to begin by expressing my heartfelt gratitude to Dr.…
New Meds and Tech – Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes
Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes Prepared on behalf of PES Drugs and…
New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage 3 Type 1 Diabetes (Ages 8-17)
New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage 3 Type 1 Diabetes (Ages 8-17) Prepared on behalf of…
New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection
New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On March…
Journal
Hormone Research in Paediatrics is the official Journal of the Pediatric Endocrine Society.